Install
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
- 95articles · 30d
- 1+ day agolatest article
- Aug 15, 2026earliest in window
- 95%with images
- 86avg words
- Health & Wellness 75
- Medical 64
- Health 31
- Science & Technology 31
- Economy, Business & Finance 27
- Finance & Business 21
- Business & Industrial 15
- Science & Nature 7
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Encoded closes $275M Series F for Dravet syndrome drug
4+ day, 15+ hour ago (75+ words) Endpoints News Encoded closes $275M Series F for Dravet syndrome drug Encoded Therapeutics has tacked on $275 million in new capital, closing a Series F round led…...
Beeline Medicines reports promising Phase 2 lupus data
4+ day, 22+ hour ago (81+ words) Beeline Medicines reports promising mid-stage lupus data Endpoints News Beeline Medicines reports promising mid-stage lupus data The business of advancing shelved pharma assets continues to reap…...
Pharvaris' stock jumps on pivotal success in rare genetic disease
5+ day, 14+ hour ago (157+ words) Pharvaris’ stock jumps on pivotal success in rare genetic disease Endpoints News We value your privacy We use third-party cookies that help us analyze how you use this website and store your preferences. However, you can opt out of these…...
Sandoz unveils plan for biosimilar expansion and new $300M factory in Slovenia
5+ day, 19+ hour ago (83+ words) Endpoints News Sandoz unveils plan for biosimilar expansion and new $300M factory in Slovenia LONDON — Sandoz is betting big on its newly formed biosimilar unit, as…...
Inhibrx opens door to cancer vaccine combo for its OX40 agonist
5+ day, 21+ hour ago (154+ words) Endpoints News We value your privacy We use third-party cookies that help us analyze how you use this website and store your preferences. However, you can opt out of these cookies by checking "Do Not Sell or Store My Personal…...
Roivant reports Phase 2 win for lung disease drug that it got from Bayer
5+ day, 23+ hour ago (151+ words) #ERS26: Roivant reports Phase 2 win for lung disease drug that it got from Bayer Endpoints News We value your privacy We use third-party cookies that help us analyze how you use this website and store your preferences. However, you can opt…...
FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote
6+ day, 16+ hour ago (82+ words) Endpoints News FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote AstraZeneca clinched an FDA accelerated approval for its oral SERD in certain…...
K Health is eyeing an IPO by 2029
1+ week, 5+ day ago (71+ words) Endpoints News K Health is eyeing an IPO by 2029 K Health is gearing up for a future public-market debut, CEO Allon Bloch said after a recent raise. The virtual…...
Lilly to buy TED startup Merida Biosciences in its 13th acquisition of 2026
1+ week, 6+ day ago (49+ words) Endpoints News Lilly to buy TED startup Merida Biosciences in its 13th acquisition of 2026 Think we're worth reading - tell Google. Confirm Endpoints as a trusted biopharma news source...
Biohaven strikes $795M deal for commercial partner in epilepsy
2+ week, 4+ day ago (78+ words) Endpoints News Biohaven strikes $795M deal for commercial partner in epilepsy Biohaven has found a commercial partner for its late-stage epilepsy drug. South Korea-based SK Biopharmaceuti…...